These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 12734674
1. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. Dandekar DS, Lokeshwar VB, Cevallos-Arellano E, Soloway MS, Lokeshwar BL. Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674 [Abstract] [Full Text] [Related]
2. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells. Weeraratna AT, Dalrymple SL, Lamb JC, Denmeade SR, Miknyoczki S, Dionne CA, Isaacs JT. Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797 [Abstract] [Full Text] [Related]
4. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Prostate; 2002 Nov 01; 53(3):211-7. PubMed ID: 12386921 [Abstract] [Full Text] [Related]
8. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC. Res Commun Chem Pathol Pharmacol; 1993 Mar 01; 79(3):293-312. PubMed ID: 8480076 [Abstract] [Full Text] [Related]
9. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Naik HR, Lehr JE, Pienta KJ. Anticancer Res; 1994 Mar 01; 14(6B):2617-9. PubMed ID: 7872690 [Abstract] [Full Text] [Related]
10. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C. Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925 [Abstract] [Full Text] [Related]
11. Preclinical antitumor activity of the oral platinum analog satraplatin. Wosikowski K, Lamphere L, Unteregger G, Jung V, Kaplan F, Xu JP, Rattel B, Caligiuri M. Cancer Chemother Pharmacol; 2007 Sep 15; 60(4):589-600. PubMed ID: 17541592 [Abstract] [Full Text] [Related]
12. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. Schwock J, Pham NA, Cao MP, Hedley DW. Cancer Chemother Pharmacol; 2008 Apr 15; 61(4):669-81. PubMed ID: 17579866 [Abstract] [Full Text] [Related]
13. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U. Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617 [Abstract] [Full Text] [Related]
14. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ. Clin Cancer Res; 2005 May 01; 11(9):3475-84. PubMed ID: 15867250 [Abstract] [Full Text] [Related]
15. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers. Sarosdy MF, Higdon AL, Demoor CA. J Urol; 1996 Jun 01; 155(6):2085-9. PubMed ID: 8618341 [Abstract] [Full Text] [Related]
16. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT. Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707 [Abstract] [Full Text] [Related]